Back

Predicting repeat revascularization after percutaneous coronary intervention: target lesion versus nontarget lesion revascularization

29 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - Mechanisms of restenosis - Its predictors and treatment Restenosis ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Seung-Woon Rha

Korea University Guro Hospital, Seoul (Korea (Republic of))

19 More presentations in this session

Presentation thumbnail
Professor U. Canpolat (Ankara, TR)
Abstract Slides
Presentation thumbnail
Doctor S. Ebisawa (Toyohashi, JP)
Abstract
Presentation thumbnail
Associate Professor G. Giannopoulos (Thessaloniki, GR)
Abstract Slides
Presentation thumbnail
Professor G. Bajraktari (Pristina, XK)
Abstract Slides
Presentation thumbnail
Professor W. Shen (Shanghai, CN)
Abstract Slides

Access the full session

Session thumbnail
Poster session 4 - Mechanisms of restenosis - Its predictors and treatment

The Event

Event poster

ESC Congress 2016

29 August 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Repeat coronary revascularization in high-risk patients treated with ticagrelor monotherapy after PCI: Insights from the randomized TWILIGHT trial
28 August 2023
thumbnail
Congress Presentation
Side branch long lesion with main vessel vulnerable plaques by optical coherence tomography predict target-vessel myocardial infarction after provisional stenting in patients with coronary bifurcation
28 August 2020
thumbnail
Congress Presentation
Quantitative flow ratio to predict non-target-vessel-related events at 5 years in STEMI patients undergoing angiography-guided revascularization
29 August 2020
thumbnail
Congress Presentation
Malnutrition is a major factor to affect prognosis of patients undergo percutaneous coronary intervention for coronary artery disease with calcified lesions
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources